MLchartDataset catalogue

Jemperli

Term · Oncology and biomedicine · MLC-T-ONC-004581

A drug used alone or with other drugs to treat adults with certain types of endometrial cancer or other solid tumors that have come back or are advanced. These include cancers that have certain mutations (changes) in genes involved in DNA repair. It is also being studied in the treatment of other types of cancer. Jemperli binds to a protein called PD-1, which is found on T cells (a type of immune cell). Jemperli may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called dostarlimab.

Table 1. Record
IdentifierMLC-T-ONC-004581
FieldOncology and biomedicine
Synonymsdostarlimab
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004581",
  "term": "Jemperli",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with certain types of endometrial cancer or other solid tumors that have come back or are advanced. These include cancers that have certain mutations (changes) in genes involved in DNA repair. It is also being studied in the treatment of other types of cancer. Jemperli binds to a protein called PD-1, which is found on T cells (a type of immune cell). Jemperli may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called dostarlimab.",
  "synonyms": [
    "dostarlimab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/jemperli/"
}

Record 9,692 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.